Dividends of Cosmo Pharmaceuticals N.V. (id:13088 COPN)
Comperitors' Dividend Yield
| Company | Market Cap USD | Dividend yield | Payout ratio | CAGR 3 years | CAGR 5 years | ||
|---|---|---|---|---|---|---|---|
|
Eli Lilly & |  |
715.22B | 0.690 % | 54.20 % | 4.63 % | 8.54 % |
|
Johnson & Johnson | |
368.63B | 3.24 % | 80.33 % | -4.10 % | -0.170 % |
|
AbbVie | |
296.46B | 3.70 % | 213.59 % | 7.84 % | 10.52 % |
|
Merck & | |
244.26B | 3.16 % | 64.44 % | 6.08 % | 8.26 % |
|
Roche Holding AG |  |
239.50B | 15.33 % | 72.51 % | 1.82 % | 2.74 % |
|
Novartis AG | |
206.61B | 14.50 % | 65.52 % | 2.75 % | 2.71 % |
|
AstraZeneca PLC |  |
201.24B | 3.10 % | 72.14 % | 2.79 % | 3.04 % |
|
Amgen | |
149.84B | 3.13 % | 113.41 % | 10.01 % | 10.04 % |
|
Pfizer | |
140.88B | 6.74 % | 222.67 % | -22.68 % | 3.82 % |
|
Sanofi |  |
124.06B | 16.55 % | 104.74 % | 4.16 % | 3.28 % |
Boxes
Dividend Yield
12.80 %
Payout Ratio
0.000 %
Compound average growth rate 3 years
0.000 %
Dividend Increase Track Record
1 Years
Latest Dividend
July 12th, 2024
Ex-Dividend Date
July 10th, 2024
Payout frequency
Yearly
Dividend Yield vs Market (countryid: 161, industryId: 134, sectorId: 19 )
Payout Ratio vs Market
Not enough data
Dividend Yield Range
Yield on cost
Dividend payout history
Dividend yield history
Dividend history
| Year | Amount | Type | Date |
|---|---|---|---|
| 2024 | 2.00 | Regular | 07-10-2024 |
| 2023 | 1.05 | Regular | 05-31-2023 |
| 2022 | 0.950 | Regular | 06-01-2022 |
| 2017 | 1.50 | Regular | 05-29-2017 |
| 2016 | 1.40 | Regular | 05-17-2016 |
| 2014 | 1.00 | Regular | 04-28-2014 |
DividendIncreaseOrDecrease
Dividend table
| Compound Average Growth Rate for last 3 years cal | 0.000 % |
| Compound Average Growth Rate for last 3 years | 0.000 % |
| Compound Average Growth Rate for last 5 years | 0.000 % |
| Compound Average Growth Rate for last 10 years | 0.000 % |
| Dividend growth | 1 years |
| Dividend growth average for all Drug Manufacturers General stocks | 6.77 years (22 stocks) |
| Dividend growth average for Ireland Drug Manufacturers General stocks | 0.500 years (2 stocks) |
| forward_annual_dividend_rate | 8.00 CHF |
| forward_annual_dividend_yield | 12.80 % |
| forward_annual_dividend_yield average for all Drug Manufacturers General stocks | 6.59 % (22 stocks) |
| forward_annual_dividend_yield average for Ireland Drug Manufacturers General stocks | 12.80 % (2 stocks) |
| trailing_annual_dividend_rate | 2.00 CHF |
| trailing_annual_dividend_yield | 3.14 % |
| trailing_annual_dividend_yield average for all Drug Manufacturers General stocks | 0.023 % (22 stocks) |
| trailing_annual_dividend_yield average for Ireland Drug Manufacturers General stocks | 0.016 % (2 stocks) |
| payout_ratio | 0.000 % |
| payout_ratio average for all Drug Manufacturers General stocks | 221.58 % (22 stocks) |
| payout_ratio average for Ireland Drug Manufacturers General stocks | 0.000 % (2 stocks) |
| dividend_date | 07-12-2024 |
| ex_dividend_date | 07-10-2024 |
Self funded chart
Years before free
| Years before free | 0 |
| Year free | 2024 |
Self funded table
| Year number | Year | Sum |
|---|
DividentYearsScore: 0
Dividened Top table
| Roche Holding AG | 27 |
| Novartis AG | 26 |
| AVG | 26.5 |
Dividened Bottom table
| Bayer AG | 1 |
| Cosmo Pharmaceuticals N.V. | 1 |
| AVG | 1 |
FAQ
Yes, Cosmo Pharmaceuticals N.V. pays a dividend. The dividend was last paid on the July 12th, 2024.
The last dividend paid by Cosmo Pharmaceuticals N.V. was CHF 2.00 per share on July 12th, 2024.
Cosmo Pharmaceuticals N.V. next scheduled ex-dividend date is July 10th, 2024.
Cosmo Pharmaceuticals N.V. has been paying dividends for the past 2 years.
No, Cosmo Pharmaceuticals N.V. does not have a history of special dividend payouts.
The payout ratio of Cosmo Pharmaceuticals N.V. is 0.000%, meaning that 0.000% of the profits are paid out as dividends.
Cosmo Pharmaceuticals N.V. dividend payout ratio of 0.000% is below the industry average of 221.58%.